BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 27248819)

  • 21. Loss of phosphatase and tensin homolog protein expression is an independent poor prognostic marker in lung adenocarcinoma.
    Yanagawa N; Leduc C; Kohler D; Saieg MA; John T; Sykes J; Yoshimoto M; Pintilie M; Squire J; Shepherd FA; Tsao MS
    J Thorac Oncol; 2012 Oct; 7(10):1513-21. PubMed ID: 22982652
    [TBL] [Abstract][Full Text] [Related]  

  • 22. DNA ploidy alterations detected during dedifferentiation of periosteal chondrosarcoma.
    Murata H; Kusuzaki K; Kuzuhara A; Takeshita H; Nakamura S; Tsuji Y; Hirasawa Y; Ashihara T
    Anticancer Res; 1999; 19(3B):2285-8. PubMed ID: 10472345
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clonality analysis and
    Yang T; Bai Y; Chen J; Sun K; Luo Y; Huang W; Zhang H
    J Bone Oncol; 2020 Jun; 22():100293. PubMed ID: 32742915
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dedifferentiated Chordoma: Clinicopathologic and Molecular Characteristics With Integrative Analysis.
    Hung YP; Diaz-Perez JA; Cote GM; Wejde J; Schwab JH; Nardi V; Chebib IA; Deshpande V; Selig MK; Bredella MA; Rosenberg AE; Nielsen GP
    Am J Surg Pathol; 2020 Sep; 44(9):1213-1223. PubMed ID: 32427623
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinico-Genomic Profiling of Conventional and Dedifferentiated Chondrosarcomas Reveals TP53 Mutation to Be Associated with Worse Outcomes.
    Denu RA; Yang RK; Lazar AJ; Patel SS; Lewis VO; Roszik J; Livingston JA; Wang WL; Shaw KR; Ratan R; Zarzour MA; Bird J; Raza S; Akdemir KC; Rodon Ahnert J; Subbiah V; Patel S; Conley AP
    Clin Cancer Res; 2023 Dec; 29(23):4844-4852. PubMed ID: 37747813
    [TBL] [Abstract][Full Text] [Related]  

  • 26. High-throughput interrogation of PIK3CA, PTEN, KRAS, FBXW7 and TP53 mutations in primary endometrial carcinoma.
    Garcia-Dios DA; Lambrechts D; Coenegrachts L; Vandenput I; Capoen A; Webb PM; Ferguson K; ; Akslen LA; Claes B; Vergote I; Moerman P; Van Robays J; Marcickiewicz J; Salvesen HB; Spurdle AB; Amant F
    Gynecol Oncol; 2013 Feb; 128(2):327-34. PubMed ID: 23219661
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A Case Report and Brief Literature Review on Dedifferentiated Chondrosarcoma in Proximal Phalanx: A Rare Location.
    Desai K; Liu S; Baskovich B; Makary R
    Cureus; 2022 Sep; 14(9):e29105. PubMed ID: 36249651
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inactivating Mutations of RB1 and TP53 Correlate With Sarcomatous Histomorphology and Metastasis/Recurrence in Gastrointestinal Stromal Tumors.
    Merten L; Agaimy A; Moskalev EA; Giedl J; Kayser C; Geddert H; Schaefer IM; Cameron S; Werner M; Ströbel P; Hartmann A; Haller F
    Am J Clin Pathol; 2016 Dec; 146(6):718-726. PubMed ID: 28028119
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Genetic alterations analysis in prognostic stratified groups identified TP53 and ARID1A as poor clinical performance markers in intrahepatic cholangiocarcinoma.
    Simbolo M; Vicentini C; Ruzzenente A; Brunelli M; Conci S; Fassan M; Mafficini A; Rusev B; Corbo V; Capelli P; Bria E; Pedron S; Turri G; Lawlor RT; Tortora G; Bassi C; Guglielmi A; Scarpa A
    Sci Rep; 2018 May; 8(1):7119. PubMed ID: 29740198
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Methylation profile of TP53 regulatory pathway and mtDNA alterations in breast cancer patients lacking TP53 mutations.
    Barekati Z; Radpour R; Kohler C; Zhang B; Toniolo P; Lenner P; Lv Q; Zheng H; Zhong XY
    Hum Mol Genet; 2010 Aug; 19(15):2936-46. PubMed ID: 20466735
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Analysis of PTEN deletions and mutations in multiple myeloma.
    Chang H; Qi XY; Claudio J; Zhuang L; Patterson B; Stewart AK
    Leuk Res; 2006 Mar; 30(3):262-5. PubMed ID: 16112193
    [TBL] [Abstract][Full Text] [Related]  

  • 32. TP53 and PTEN mutations were shared in concurrent germ cell tumor and acute megakaryoblastic leukemia.
    Akizuki K; Sekine M; Kogure Y; Kameda T; Shide K; Koya J; Kamiunten A; Kubuki Y; Tahira Y; Hidaka T; Kiwaki T; Tanaka H; Sato Y; Kataoka H; Kataoka K; Shimoda K
    BMC Cancer; 2020 Jan; 20(1):5. PubMed ID: 31898539
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Acquired isochromosome 12p, somatic TP53 and PTEN mutations, and a germline ATM variant in an adolescent male with concurrent acute megakaryoblastic leukemia and mediastinal germ cell tumor.
    Oshrine BR; Olsen MN; Heneghan M; Wertheim G; Daber R; Wilmoth DM; Biegel JA; Pawel B; Aplenc R; King RL
    Cancer Genet; 2014 Apr; 207(4):153-9. PubMed ID: 24831771
    [TBL] [Abstract][Full Text] [Related]  

  • 34. PTEN mutations and relationship to EGFR, ERBB2, KRAS, and TP53 mutations in non-small cell lung cancers.
    Jin G; Kim MJ; Jeon HS; Choi JE; Kim DS; Lee EB; Cha SI; Yoon GS; Kim CH; Jung TH; Park JY
    Lung Cancer; 2010 Sep; 69(3):279-83. PubMed ID: 20018398
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A chimeric protein PTEN-L-p53 enters U251 cells to repress proliferation and invasion.
    Xiao M; An Y; Wang F; Yao C; Zhang C; Xin J; Duan Y; Zhao X; Fang N; Ji S
    Exp Cell Res; 2018 Aug; 369(2):234-242. PubMed ID: 29802838
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Esophageal cancer in a family with hamartomatous tumors and germline PTEN frameshift and SMAD7 missense mutations.
    Sherman SK; Maxwell JE; Qian Q; Bellizzi AM; Braun TA; Iannettoni MD; Darbro BW; Howe JR
    Cancer Genet; 2015; 208(1-2):41-6. PubMed ID: 25554686
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Next generation sequencing demonstrates association between tumor suppressor gene aberrations and poor outcome in patients with cancer.
    Schwaederle M; Daniels GA; Piccioni DE; Kesari S; Fanta PT; Schwab RB; Shimabukuro KA; Parker BA; Kurzrock R
    Cell Cycle; 2015; 14(11):1730-7. PubMed ID: 25928476
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Extensive next-generation sequencing analysis in chronic lymphocytic leukemia at diagnosis: clinical and biological correlations.
    Rigolin GM; Saccenti E; Bassi C; Lupini L; Quaglia FM; Cavallari M; Martinelli S; Formigaro L; Lista E; Bardi MA; Volta E; Tammiso E; Melandri A; Urso A; Cavazzini F; Negrini M; Cuneo A
    J Hematol Oncol; 2016 Sep; 9(1):88. PubMed ID: 27633522
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Characterization of molecular genetic alterations in GBMs highlights a distinctive molecular profile in young adults.
    Jha P; Suri V; Singh G; Jha P; Purkait S; Pathak P; Sharma V; Sharma MC; Suri A; Gupta D; Mahapatra AK; Sarkar C
    Diagn Mol Pathol; 2011 Dec; 20(4):225-32. PubMed ID: 22089350
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Dedifferentiated chondrosarcoma revisited.
    Mavrogenis AF; Ruggieri P; Mercuri M; Papagelopoulos PJ
    J Surg Orthop Adv; 2011; 20(2):106-11. PubMed ID: 21838071
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.